MALIA DEJONG: Open Payments
NPI 1154870624 · OVERLAND PARK, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$590 in 25 payments from 10 companies in 2025. Trend: 2023 $329 · 2024 $322 · 2025 $590
Food & beverage: $534Education: $56
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 10 | $183 |
| Regeneron Healthcare Solutions, Inc. | 4 | $135 |
| JAZZ PHARMACEUTICALS INC. | 2 | $55 |
| Smith+Nephew, Inc. | 1 | $50 |
| GENZYME CORPORATION | 2 | $40 |
| Phathom Pharmaceuticals, Inc. | 2 | $31 |
| Integra LifeSciences Corporation | 1 | $28 |
| AstraZeneca Pharmaceuticals LP | 1 | $25 |
| Paratek Pharmaceuticals, Inc. | 1 | $25 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
Products named: NUCALA, DUPIXENT, XYWAV, HALO, VOQUEZNA, ACCLARENT AERA, TEZSPIRE, XHANCE.
Industry payments across KS — which companies pay providers there.
